Skip to content
DataLookout
Menu

NCT06692673

Linaclotide for Colonoscopy Bowel Prep

StatusTerminated
PhasePhase 1/2
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial terminated Sponsor's reason: terminated early due to futility/ineffectiveness Show 4 more changesShow less
    • Eligibility criteria expanded, about 12 words
    • Final enrollment: 4 participants (planned 10)
    • Study completion date changed from estimate of Jul 28, 2026 to Apr 7, 2026
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruitingv7 Show 4 more changesShow less
    • Start date changed from estimate of Sep 1, 2025 to Dec 1, 2025
    • Primary completion date: Dec 30, 2025 to Apr 30, 2026
    • Study completion date: Feb 28, 2026 to Jul 28, 2026
    • Site details revised
  3. Notable Start date: Jun 1, 2025 to Sep 1, 2025
    • Primary completion date: Nov 30, 2025 to Dec 30, 2025
    • Study completion date: Dec 31, 2025 to Feb 28, 2026
    v6
  4. Notable Start date: Mar 1, 2025 to Jun 1, 2025
    • Primary completion date: Aug 31, 2025 to Nov 30, 2025
    v5
  5. Notable Start date: Jan 9, 2025 to Mar 1, 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Dec 1, 2024 to Jan 9, 2025v3
  2. Notable Phase: Early Phase 1 to Phase 1/2v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

BBPS a cutoff 6 or greater
Timeframe: Within 48 hours post Colonoscopy

Arms and interventions

Patients scheduled for ColonoscopyExperimental

Adult in-patients, 18 years of age and older, scheduled for an in-patient screening or diagnostic colonoscopy

Drugs: Use of Linaclotide as a single agent Colonoscopy prep

Sites

1 site in 1 country

  • UF HealthGainesville, Florida, United States